Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)GM-CSF as Adjuvant Therapy of Melanoma
Phase 2
Completed
- Conditions
- Malignant Melanoma
- First Posted Date
- 2006-07-11
- Last Posted Date
- 2006-07-11
- Lead Sponsor
- Northern California Melanoma Center
- Target Recruit Count
- 50
- Registration Number
- NCT00350597
- Locations
- 🇺🇸
Northern California Melanoma Center, San Francisco, California, United States
Temodar and Sutent as Therapy for Melanoma
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Northern California Melanoma Center
- Target Recruit Count
- 7
- Registration Number
- NCT00304200
- Locations
- 🇺🇸
Northern California Melanoma Center, San Francisco, California, United States
News
No news found